Look behind the lecture: patient-preference information in HTA


In this feature, following participating in a plenary session at the International Society for Pharmacoeconomics and Outcomes Research’s 2020 virtual Europe meeting (Virtual ISPOR Europe 2020; 16–19 November), Axel Mühlbacher (Hochschule Neubrandenburg, Germany) discusses the relevance of patient-preference information in decision-making and health technology assessment (HTA). Please could you introduce yourself, your organization(s) and provide a brief summary of your career to date? I am a Professor of Health Economics and Healthcare Management at Hochschule Neubrandenburg (Germany) and an Adjunct Professor at the Duke Department of Population Health Sciences (NC, USA). I am also affiliated, as a Senior Researcher, with...

To view this content, please register now for access

It's completely free